Novo Nordisk, a global healthcare company, has been committed to discovering and developing innovative medicines to help people with diabetes lead longer, healthier lives for 95 years. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions including hemophilia, growth disorders and obesity. With U.S. headquarters in NJ we employ nearly 6,000 people throughout the country.